+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 100Years
All Genders
Healthy Volunteers
ID07575061

A 15-Year Study of Risk Factors Linked to Death in Patients With Intestinal Tuberculosis at Beijing Chest Hospital

Led by Beijing Chest Hospital, Capital Medical University · Updated on 2026-05-08

500

Participants Needed

1

Research Sites

521 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are conducting a combined retrospective and prospective cohort study at Beijing Chest Hospital to identify risk factors linked to mortality in patients with intestinal tuberculosis. The study first analyzes data collected over 15 years 2011 to 2025 from patients diagnosed and followed at the hospital. Using statistical methods, the study aims to find factors like age, disease severity, other illnesses, and treatment adherence that may impact survival. The study includes two groups a retrospective cohort of patients diagnosed between 2011 and 2025 whose historical medical records and follow-up data are reviewed, and a prospective cohort of newly diagnosed patients enrolled after 2026 who will be followed over time. Data collected include demographics, clinical symptoms, laboratory tests, treatment details, and mortality outcomes to verify and supplement the findings from the first phase. Participants will provide clinical information through medical records or ongoing follow-up visits, allowing researchers to monitor their health status and treatment responses. Outcome measures focus on all-cause mortality, tracked over 15 years for the retrospective group and for 3 years from enrollment for the prospective group. This research helps improve understanding of factors influencing survival and may guide better management strategies for intestinal tuberculosis patients.

CONDITIONS

Brief Title

A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal Tuberculosis

Research Team

X

Xuelian X Li, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here